top of page

Final results from the INO-VATE ALL study of inotuzumab ozogamicin

Final findings from the Phase III INO-VATE ALL evaluating the safety and efficacy of inotuzumab ozogamicin in acute lymphoblastic leukaemia (ALL) have been announced.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page